The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Genetic and Pharmacological Suppression of Oncogenic Mutations in RAS Genes of Yeast and Humans
Abstract
The activity of an oncoprotein and the secretion of a pheromone can be affected by an unusual protein modification. Specifically, posttranslational modification of yeast a-factor and Ras protein requires an intermediate of the cholesterol biosynthetic pathway. This modification is apparently essential for biological activity. Studies of yeast mutants blocked in sterol biosynthesis demonstrated that the membrane association and biological activation of the yeast Ras2 protein require mevalonate, a precursor of sterols and other isoprenes such as farnesyl pyrophosphate. Furthermore, drugs that inhibit mevalonate biosynthesis blocked the in vivo action of oncogenic derivatives of human Ras protein in the Xenopus oocyte assay. The same drugs and mutations also prevented the posttranslational processing and secretion of yeast a-factor, a peptide that is farnesylated. Thus, the mevalonate requirement for Ras activation may indicate that attachment of a mevalonate-derived (isoprenoid) moiety to Ras proteins is necessary for membrane association and biological function. These observations establish a connection between the cholesterol biosynthetic pathway and transformation by the ras oncogene and offer a novel pharmacological approach to investigating, and possibly controlling, ras -mediated malignant transformations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sherman, F., Fink, G. R., & Hicks, J. B. (1979) · Cold Spring Harbor Laboratory eBooks · Cited by 7,430
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,114
Alberts, A. W., Chen, J., Kuron, G., Hunt, V, Huff, J., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,628
A Cytoplasmic Protein Stimulates Normal N- ras p21 GTPase, But Does Not Affect Oncogenic Mutants
Trahey, M., & McCormick, F. (1987) · Science · doi:10.1126/science.2821624 · Cited by 1,211
In yeast, RAS proteins are controlling elements of adenylate cyclase
Toda, T., Uno, I., Ishikawa, T., Powers, S., Kataoka, T., Broek, D., Cameron, S., Broach, J., Matsumoto, K., & Wigler, M. (1985) · Cell · doi:10.1016/0092-8674(85)90305-8 · Cited by 1,108
A ras-like protein is required for a post-Golgi event in yeast secretion
Salminen, A., & Novick, P. J. (1987) · Cell · doi:10.1016/0092-8674(87)90455-7 · Cited by 897
Furth, M. E., Davis, L. J., Fleurdelys, B., & Scolnick, E. M. (1982) · Journal of Virology · doi:10.1128/jvi.43.1.294-304.1982 · Cited by 800
Endo, A., Kuroda, M., & Tanzawa, K. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80996-9 · Cited by 794
Cited by
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Takai, Y., Sasaki, T., & Matozaki, T. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.153 · Cited by 2,475
Aaronson, S. A. (1991) · Science · doi:10.1126/science.1659742 · Cited by 2,028
RAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902
Ras oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467
Milburn, M. V., Tong, L., deVos, A. M., Brünger, A., Yamaizumi, Z., Nishimura, S., & Kim, S.-H. (1990) · Science · doi:10.1126/science.2406906 · Cited by 1,059
Self-citationNatural and synthetic non-peptide antigens recognized by human γδ T cells
Tanaka, Y., Morita, C. T., Tanaka, Y., Nieves, E., Brenner, M. B., & Bloom, B. R. (1995) · Nature · doi:10.1038/375155a0 · Cited by 1,013
The discovery and development of HMG-CoA reductase inhibitors.
Endo, A. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41379-3 · Cited by 847
Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides
Reiss, Y., Goldstein, J. L., Seabra, M. C., Casey, P. J., & Brown, M. S. (1990) · Cell · doi:10.1016/0092-8674(90)90242-7 · Cited by 817
Ras history: The saga continues
Cox, A. D., & Der, C. J. (2010) · Small GTPases · doi:10.4161/sgtp.1.1.12178 · Cited by 706
Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation In Animal Cells
James, G. L., Goldstein, J. L., Brown, M. S., Rawson, T. E., Somers, T. C., McDowell, R. S., Crowley, C. W., Lucas, B. K., Levinson, A. D., & Marsters, J. C. (1993) · Science · doi:10.1126/science.8316834 · Cited by 630
The ras protein family: evolutionary tree and role of conserved amino acids
Valencia, A., Chardin, P., Wittinghofer, A., & Sander, C. (1991) · Biochemistry · doi:10.1021/bi00233a001 · Cited by 573
Johnson, D. I., & Pringle, J. R. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.1.143 · Cited by 555
Protein prenylation: unique fats make their mark on biology
Wang, M., & Casey, P. J. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.11 · Cited by 547
Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development
Rowinsky, E. K., Windle, J. J., & Von Hoff, D. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3631 · Cited by 537
Posttranslational modification of proteins by isoprenoids in mammalian cells
Maltese, W. A. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.15.2123808 · Cited by 519
Takai, Y., Kaibuchi, K., Kikuchi, A., & Kawata, M. (1992) · International Review of Cytology · doi:10.1016/s0074-7696(08)61861-6 · Cited by 516
Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies
Jiang, H., Zhang, X., Chen, X., Aramsangtienchai, P., Tong, Z., & Lin, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00750 · Cited by 500
Prenyl proteins in eukaryotic cells: a new type of membrane anchor
Glomset, J. A., Gelb, M. H., & Farnsworth, C. C. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90213-u · Cited by 466
Saccharomyces cerevisiae STE6 gene product: a novel pathway for protein export in eukaryotic cells.
Kuchler, K., Sterne, R. E., & Thorner, J. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08580.x · Cited by 442
Self-citationPlutner, H., Cox, A. D., Pind, S., Khosravi-Far, R., Bourne, J. R., Schwaninger, R., Der, C. J., & Balch, W. E. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.1.31 · Cited by 392
Role of Farnesyltransferase in ABA Regulation of Guard Cell Anion Channels and Plant Water Loss
Pei, Z.-M., Ghassemian, M., Kwak, C. M., McCourt, P., & Schroeder, J. I. (1998) · Science · doi:10.1126/science.282.5387.287 · Cited by 390
Farnesylated γ-subunit of photoreceptor G protein indispensable for GTP-binding
Fukada, Y., Takao, T., Ohguro, H., Yoshizawa, T., Akino, T., & Shimonishi, Y. (1990) · Nature · doi:10.1038/346658a0 · Cited by 385
PROTEIN PRENYLATION: GENES, ENZYMES, TARGETS, AND FUNCTIONS
Schafer, W. R., & Rine, J. (1992) · Annual Review of Genetics · doi:10.1146/annurev.ge.26.120192.001233 · Cited by 377
Self-citationDirect Demonstration of Geranylgeranylation and Farnesylation of Ki-Ras in Vivo
Rowell, C. A., Kowalczyk, J. J., Lewis, M. D., & Garcia, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14093 · Cited by 368
Crystal Structure of Protein Farnesyltransferase at 2.25 Angstrom Resolution
Park, H.-W., Boduluri, S. R., Moomaw, J. F., Casey, P. J., & Beese, L. S. (1997) · Science · doi:10.1126/science.275.5307.1800 · Cited by 338
Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation.
Jackson, J. H., Cochrane, C. G., Bourne, J. R., Solski, P. A., Buss, J. E., & Der, C. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3042 · Cited by 338
Identification of a Prenylation Site in Delta Virus Large Antigen
Glenn, J. S., Watson, J. A., Havel, C. M., & White, J. M. (1992) · Science · doi:10.1126/science.1598578 · Cited by 327
THE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICS
Gibbs, J. B., & Oliff, A. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.143 · Cited by 324
Human Lamin B Contains a Farnesylated Cysteine Residue
Farnsworth, C. C., Wolda, S. L., Gelb, M. H., & Glomset, J. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47079-8 · Cited by 323
Biological effects of oxysterols: Current status
Guardiola, F., Codony, R., Addis, P. B., Rafecas, M., & Boatella, J. (1996) · Food and Chemical Toxicology · doi:10.1016/0278-6915(95)00094-1 · Cited by 322
Sequence requirement for peptide recognition by rat brain p21ras protein farnesyltransferase.
Reiss, Y., Stradley, S. J., Gierasch, L. M., Brown, M. S., & Goldstein, J. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.732 · Cited by 313
Regulators and Effectors of ras Proteins
Bollag, G., & McCormick, F. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.003125 · Cited by 300
Protein kinase C: a paradigm for regulation of protein function by two membrane-targeting modules
Newton, A. C., & Johnson, J. E. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(98)00003-3 · Cited by 274
Crowell, P. L., Chang, R. R., Ren, Z. B., Elson, C. E., & Gould, M. N. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47425-5 · Cited by 268
Tong, L., de Vos, A. M., Milburn, M. V., & Kim, S.-H. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90753-s · Cited by 260
Self-citationSelective inhibition of farnesyl-protein transferase blocks ras processing in vivo.
Gibbs, J. B., Pompliano, D. L., Mosser, S. D., Rands, E., Lingham, R. B., Singh, S. B., Scolnick, E. M., Kohl, N. E., & Oliff, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52998-7 · Cited by 260
Protein Prenylation: Enzymes, Therapeutics, and Biotechnology Applications
Palsuledesai, C. C., & Distefano, M. D. (2015) · ACS Chemical Biology · doi:10.1021/cb500791f · Cited by 259
Butyrate and the Colonocyte: Production, Absorption, Metabolism, and Therapeutic Implications
Velázquez, O. C., Lederer, H. M., & Rombeau, J. L. (1997) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-5967-2_14 · Cited by 258
Identification of Ras farnesyltransferase inhibitors by microbial screening.
Hara, M., Akasaka, K., Akinaga, S., Okabe, M., Nakano, H., Gomez, R., Wood, D., Uh, M., & Tamanoi, F. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2281 · Cited by 257
The Multifaceted Biology of PCSK9
Seidah, N. G., & Prat, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab035 · Cited by 232
Osterweil, E. K., Chuang, S.-C., Chubykin, A. A., Sidorov, M., Bianchi, R., Wong, R. K. S., & Bear, M. F. (2013) · Neuron · doi:10.1016/j.neuron.2012.01.034 · Cited by 230
Zhang, F. L., Kirschmeier, P., Carr, D., James, L., Bond, R. W., Wang, L., Patton, R., Windsor, W. T., Syto, R., Zhang, R., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.10232 · Cited by 197
Carboxyl-terminal isoprenylation of ras-related GTP-binding proteins encoded by rac1, rac2, and ralA
Kinsella, B. T., Erdman, R. A., & Maltese, W. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92889-9 · Cited by 131
RAM2: an essential gene in the prenylation pathway of Candida albicans
Song, J. L. (2003) · Microbiology · doi:10.1099/mic.0.25887-0 · Cited by 38
Lovastatin, Not Simvastatin, Corrects Core Phenotypes in the Fragile X Mouse Model
Muscas, M., Louros, S. R., & Osterweil, E. K. (2019) · eneuro · doi:10.1523/eneuro.0097-19.2019 · Cited by 30
Metadata
- Authors
- Schafer, W. R., Kim, R., Sterne, R., Thorner, J., Kim, S.-H., & Rine, J.
- Venue
- Science
- Published
- 1989-07-28
- Volume
- 245
- Issue
- 4916
- Pages
- 379-385
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2090702802
- Cited by
- 530
- References
- 63
- FWCI
- 24.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.